日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Alisol B Alleviates Hepatocyte Lipid Accumulation and Lipotoxicity via Regulating RARα-PPARγ-CD36 Cascade and Attenuates Non-Alcoholic Steatohepatitis in Mice

泽泻醇B通过调控RARα-PPARγ-CD36级联减轻肝细胞脂质蓄积和脂毒性并减轻小鼠非酒精性脂肪性肝炎

Zhuohui Zhao, Zhen-Tao Deng, Suling Huang, Mengmeng Ning, Ying Feng, Yu Shen, Qin-Shi Zhao, Ying Leng

An integrative drug repositioning framework discovered a potential therapeutic agent targeting COVID-19

综合药物重新定位框架发现了一种针对 COVID-19 的潜在治疗剂

Yiyue Ge #, Tingzhong Tian #, Suling Huang #, Fangping Wan #, Jingxin Li #, Shuya Li, Xiaoting Wang, Hui Yang, Lixiang Hong, Nian Wu, Enming Yuan, Yunan Luo, Lili Cheng, Chengliang Hu, Yipin Lei, Hantao Shu, Xiaolong Feng, Ziyuan Jiang, Yunfu Wu, Ying Chi, Xiling Guo, Lunbiao Cui, Liang Xiao, Zeng L

A new mechanism of obeticholic acid on NASH treatment by inhibiting NLRP3 inflammasome activation in macrophage

奥贝胆酸抑制巨噬细胞NLRP3炎症小体活化治疗NASH的新机制

Suling Huang, Yanwei Wu, Zhuohui Zhao, Bing Wu, Kai Sun, Haoyu Wang, Li Qin, Fang Bai, Ying Leng, Wei Tang

Activation of SIK1 by phanginin A inhibits hepatic gluconeogenesis by increasing PDE4 activity and suppressing the cAMP signaling pathway

phginin A 激活 SIK1 可增加 PDE4 活性并抑制 cAMP 信号通路,从而抑制肝糖异生

Siwen Liu, Suling Huang, Xingde Wu, Ying Feng, Yu Shen, Qin-Shi Zhao, Ying Leng